title: The use of hydroxyapatite and autogenous cancellous bone grafts to repair bone defects in rats.
abstract: Bone grafts are frequently used in the treatment of bone defects. Bone harvesting can cause postoperative complications and sometimes does not provide a sufficient quantity of bone. Therefore, synthetic biomaterials have been investigated as an alternative to autogenous bone grafts. The objective of this study was to evaluate the repair of bone defects by autogenous cancellous bone grafts or porous bioceramic discs of hydroxyapatite/phosphate cement mixture. Two 5-mm diameter defects were made in the skulls of rats and filled with the bioceramic material or cancellous bone. The rats were sacrificed 2, 4, 8 and 24 weeks after surgery and tissue samples were analyzed by radiography and histology. By the 24th week, the defects filled with autogenous cancellous bone grafts or bioceramic material showed similar volumes of bone tissue within the defect. However, defects treated with bioceramic material were almost completely closed as a result of the joining of ceramic fragments and the neoformed bone tissue, while those filled with autogenous grafts showed several areas filled with connective tissue. These results indicated that the osteointegration of bioceramic fragments allowed the reconstruction of parietal bone defects without the need for a bone graft.
authors.affiliation: Department of Anatomy, Institute of Biology, State University of Campinas, Campinas, São Paulo, Brazil.
authors.forename: R V
authors.initials: RV
authors.lastname: Silva
authors.forename: J A
authors.initials: JA
authors.lastname: Camilli
authors.forename: C A
authors.initials: CA
authors.lastname: Bertran
authors.forename: N H
authors.initials: NH
authors.lastname: Moreira
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry / Q000627:therapeutic use*; D001843:Bone Cements / Q000737:chemistry / Q000627:therapeutic use; D001847:Bone Diseases / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D018786:Bone Substitutes / Q000737:chemistry / Q000627:therapeutic use*; D016025:Bone Transplantation / Q000000981:diagnostic imaging / Q000473:pathology; D002130:Calcium Phosphates / Q000737:chemistry / Q000627:therapeutic use; D003238:Connective Tissue / Q000473:pathology; D017886:Durapatite / Q000737:chemistry / Q000627:therapeutic use*; D008297:Male; D016348:Osseointegration / Q000502:physiology; D010012:Osteogenesis / Q000502:physiology; D010294:Parietal Bone / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D016062:Porosity; D011859:Radiography; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D014182:Transplantation, Autologous; D014945:Wound Healing / Q000502:physiology
chemical_list: D001672:Biocompatible Materials; D001843:Bone Cements; D018786:Bone Substitutes; D002130:Calcium Phosphates; D017886:Durapatite